Wei Yang

Insights And Considerations From The Invalidation Case As To Ruxolitinib

Definition And Acceptable Conditions For "Disclaimer Amendment" From The Second-Instance Judgment Of The "Zirconia Case"

Judicial Interpretation Regarding Patent Linkage

NMPA And CNIPA Issued Measures For The Implementation Of Early Resolution Mechanisms For Drug Patent Disputes On July 4, 2021

Changes To Biotech And Chemical Patent Examination - Recent Amendments To Guidelines For Patent Examination

Interpretation Of Markush Claims In A Recent Supreme People's Court Decision

China Accepts Overseas Clinical Trial Data Of Drugs